GLOW+
High-Load Dermatological Research Blend - GHK-Cu-forward blend with BPC-157 & TB-500 for skin-research protocols.
GLOW+ is a co-formulated blend that pairs a high load of the copper peptide GHK-Cu (100mg) with BPC-157 (10mg) and TB-500 (10mg), prepared for dermatological and regenerative research where the copper-peptide arm is the primary variable.
Blends are characterized as a whole on the lot certificate, so the purity and identity figures describe the co-formulated preparation. Work with this higher-copper version generally weights the copper-delivery and matrix-remodeling route over the repair-peptide arm, which is the main reason to choose it over the standard Glow ratio.
GLOW+ specifications
- Molecular formula
- Co-formulated blend
- Sequence
- GHK-Cu 100mg + BPC-157 10mg + TB-500 10mg
- Residues
- GHK-Cu + BPC-157 + TB-500
- Presentation
- Blue lyophilized powder
- Documented purity
- 99.89% by HPLC
- Available sizes
- 120mg ($125)
- Archived COA lots
- 1
- Intended use
- Laboratory research use only. Not for human or veterinary use.
Studied pathways
- Skin matrix study - Investigated for combined collagen-signaling and repair activity in skin models, weighted toward the copper-peptide component.
Reported mechanisms in the literature
- Skin-matrix study - Pairs a high copper-peptide load with two repair peptides for study of collagen-signaling and repair activity together in skin-research models. (Combination research)
- GHK-Cu arm - GHK-Cu is studied for copper delivery and extracellular-matrix gene regulation in fibroblast models. (Pickart et al.)
What GLOW+ is researched for
- Skin renewal - Studied for combined collagen-signaling and tissue-repair activity in skin-research models, weighted toward the copper-peptide arm. (Combination research)
- Matrix remodeling - Investigated for overlapping matrix and repair pathways across its component peptides. (Preclinical literature)
GLOW+ certificates of analysis on file
Every lot below was tested by an independent laboratory and the full report is published as a PDF. Purity is shown exactly as the report states it. The same records are searchable in the COA library and can be checked on the lot verification page.
| Lot | Tested | Size | Laboratory | HPLC purity | Identity | Certificate |
|---|---|---|---|---|---|---|
| 377PG1 | 10 Oct 2026 | 120mg | Freedom Diagnostics | 99.89% | Confirmed (LC-MS/MS) | COA PDF |
Published literature on GLOW+
The mechanisms above trace to peer-reviewed studies indexed on PubMed. These are independent third-party publications, not Aspect Peptides claims. Browse indexed research on PubMed.
GLOW+ frequently asked questions
How does GLOW+ differ from Glow?
GLOW+ carries 100mg of GHK-Cu with 10mg each of BPC-157 and TB-500 (120mg total), so the copper-peptide arm is the dominant component.
Is GLOW+ approved for cosmetic or human use?
No. It is a laboratory research material only; it is not a cosmetic, drug, or supplement.
How is it documented?
Each lot ships with its Certificate of Analysis, which reports the blend's identity and purity.
Documented to 99.89% purity by HPLC · third-party COA every lot · from $125 · For laboratory research use only.
Related Regenerative & Repair compounds
- BPC-157 - Synthetic pentadecapeptide studied for VEGF and growth-factor receptor signaling.
- TB-500 - Thymosin β-4 fragment studied for actin regulation and tissue repair.
- BPC-157 / TB-500 - Co-formulated repair-research blend in a single vial.
- BPC-157 / TB-500 / KPV - BPC-157, TB-500 and KPV co-formulated in a single vial.
- GHK-Cu - Copper tripeptide studied in skin-remodeling research.
- KPV - α-MSH C-terminal fragment studied for inflammatory signaling.